PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1401843
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1401843
According to Stratistics MRC, the Global Piezoelectric Biosensors Market is accounted for $27.9 billion in 2023 and is expected to reach $51.4 billion by 2030 growing at a CAGR of 9.1% during the forecast period. A class of analytical instruments known as piezoelectric biosensors uses the piezoelectric effect to monitor the electrical potential generated when mechanical force is applied to a piezoelectric material. They have a high degree of sensitivity and are modest in size. Since these sensors can provide an output signal based just on the applied strain, they don't need any external sources of voltage or current.
Multiplexing capabilities
Multiple analytes can be detected in parallel during a single test thanks to multiplexing. This boosts the biosensor's throughput and makes it possible to analyze more targets faster. Furthermore, this is especially useful in scenarios when sample sizes are few or limited, such in diagnostic medical settings where little amounts of blood or other biofluids are accessible. Furthermore, it aids in resource conservation. Thus, these are the variables impacting the market's expansion.
Temperature sensitivity
Temperature fluctuations can have an impact on the accuracy and dependability of a sensor made of piezoelectric materials. Variations in temperature have the potential to induce baseline drift and affect the biosensor's overall performance. Piezoelectric biosensors may also be complicated to develop and make, requiring specific expertise and equipment. Their incorporation into lightweight and portable devices can be hampered by their intricacy. These are the aspects that are limiting the market's expansion.
Regulatory Compliance
Piezoelectric biosensor research, marketing, and acceptance are significantly influenced by regulatory compliance. Strict validation of biosensor performance is typically required to meet regulatory compliance norms. To comply with regulatory standards, producers and developers of piezoelectric biosensors must finance thorough validation investigations. By emphasizing validation, biosensor data become more reliable and are more readily accepted in vital applications like medical diagnostics. These are the factors influencing the market's growth.
High price of biosensors
The high cost of manufacturing piezoelectric biosensors may prevent their widespread use, particularly in settings with limited resources. The widespread deployment of piezoelectric biosensors depends on the development of cost-effective, highly sensitive versions of these sensors. Research on materials and production techniques that are cost-effective is still underway. This is the main factor impeding the market's expansion.
Point-of-care testing using piezoelectric biosensors enables rapid and decentralized testing in locations such as clinics, airports, and even homes. The COVID-19 pandemic has made such testing skills more necessary. Similar to several technologies, the advancement and manufacturing of piezoelectric biosensors may be impacted by disturbances in the worldwide supply chain resulting from the pandemic. This might have an effect on the price and availability of parts needed for these sensors.
The polymers segment is expected to be the largest during the forecast period
The polymers segment is expected to be the largest during the forecast period. Thin coatings of piezoelectric polymers are frequently applied on the surface of quartz crystals or other piezoelectric substrates. By promoting the contact between the biological analyte and the sensing surface, these coatings increase the biosensor's sensitivity. These materials are appropriate for sensing applications because they may produce a piezoelectric response when mechanical stress is applied.
The aluminum segment is expected to have the highest CAGR during the forecast period
The aluminum segment is expected to have the highest CAGR during the forecast period. Devices that use the piezoelectric effect to sense mass changes or binding events on the sensor surface are known as piezoelectric biosensors. These sensors are often employed in many different fields, including as food safety, environmental monitoring, and medical diagnostics. Other materials, such as quartz or ceramics, are frequently utilized for the active sensing element in piezoelectric biosensors aluminum is not a popular material.
North America is projected to hold the largest market share during the forecast period. Piezoelectric biosensors detect mass changes on the sensor surface, frequently as a result of interactions between molecules, by using the piezoelectric effect. The development and use of piezoelectric biosensors for a variety of applications, including environmental monitoring, and medical diagnostics, has engaged several research institutes, universities, and businesses. With great sensitivity and specificity, these biosensors have demonstrated the ability to identify certain biomolecules, infections, and other analytes.
Asia Pacific is projected to hold the highest CAGR over the forecast period. Piezoelectric biosensors detect mass changes on the sensor surface, frequently as a result of interactions between molecules, by using the piezoelectric effect. The development and use of piezoelectric biosensors for a variety of applications, including food safety, environmental monitoring, and medical diagnostics, has engaged several research institutes, universities, and businesses. With great sensitivity and specificity, these biosensors have demonstrated the ability to identify certain biomolecules, infections, and other analytes.
Some of the key players in Piezoelectric Biosensors market include ACON Laboratories, F. Hoffmann-La Roche, Siemens, Universal Biosensors, LifeSensors, Medtronic, Abbott Point of Care, Pharmaco Kinesis, Bayer AG, LifeScan, DuPont, LifeScan IP Holdings, LLC, Conductive Technologies and Innovative Sensor Technology IST AG.
In March 2022, Medtronic announced partnership with Rockley Photonics to launch Bioptx biomarker sensing platform across various healthcare settings. The new biosensor is a single wearable device that is capable of monitoring multiple crucial biomarkers including body temperature, blood pressure, body hydration, alcohol, lactate and glucose trends among others.
In January 2022, Abbott launched a new category of consumer bio wearables, called Lingo. This new device is designed to track key signals in the body such as glucose, ketones and lactate, enabling people to understand health better and take action.